FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 235 filers reported holding FATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $463,680 | -82.9% | 46,000 | -62.0% | 0.14% | -83.6% |
| Q3 2022 | $2,712,000 | -98.3% | 121,000 | +2989.1% | 0.87% | -47.2% |
| Q2 2022 | $158,000,000 | +2700.9% | 3,917 | -86.0% | 1.65% | +29.6% |
| Q1 2022 | $5,641,000 | +244.4% | 28,000 | 0.0% | 1.27% | +248.5% |
| Q4 2021 | $1,638,000 | -1.3% | 28,000 | 0.0% | 0.36% | -8.8% |
| Q3 2021 | $1,660,000 | – | 28,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |